Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $8.0000 (-5.66%) ($8.0000 - $8.4800) on Wed. Apr. 17, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.14% (three month average) | RSI | 73 | Latest Price | $8.0000(-5.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -2.5% a day on average for past five trading days. | Weekly Trend | EYES advances 14.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(9%) UUP(9%) ICLN(6%) UNG(6%) FIVG(5%) | Factors Impacting EYES price | EYES will decline at least -2.57% in a week (0% probabilities). BND(-8%) LQD(-6%) XLP(-5%) VCIT(-5%) TIP(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.57% (StdDev 5.14%) | Hourly BBV | 0 () | Intraday Trend | -5.7% | | | |
|
5 Day Moving Average | $8.49(-5.77%) | 10 Day Moving Average | $7.98(0.25%) | 20 Day Moving Average | $7.27(10.04%) | To recent high | -12.3% | To recent low | 46% | Market Cap | $2.555b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |